Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results